GSDME and hepatocellular carcinoma: Furthermore, inhibiting GSDME palmitoylation reversed the enhanced pyroptosis induced by Lenvatinib in GSDME-overexpressing HCC cells, demonstrating that disrupting GSDME palmitoylation impairs Lenvatinib-induced pyroptosis in HCC cells.